Product NDC: | 55154-9726 |
Proprietary Name: | Renagel |
Non Proprietary Name: | sevelamer hydrochloride |
Active Ingredient(s): | 400 mg/1 & nbsp; sevelamer hydrochloride |
Administration Route(s): | ORAL |
Dosage Form(s): | TABLET |
Coding System: | National Drug Codes(NDC) |
Product NDC: | 55154-9726 |
Labeler Name: | Cardinal Health |
Product Type: | HUMAN PRESCRIPTION DRUG |
FDA Application Number: | NDA021179 |
Marketing Category: | NDA |
Start Marketing Date: | 20080606 |
Package NDC: | 55154-9726-4 |
Package Description: | 360 POUCH in 1 CARTON (55154-9726-4) > 1 TABLET in 1 POUCH (55154-9726-6) |
NDC Code | 55154-9726-4 |
Proprietary Name | Renagel |
Package Description | 360 POUCH in 1 CARTON (55154-9726-4) > 1 TABLET in 1 POUCH (55154-9726-6) |
Product NDC | 55154-9726 |
Product Type Name | HUMAN PRESCRIPTION DRUG |
Non Proprietary Name | sevelamer hydrochloride |
Dosage Form Name | TABLET |
Route Name | ORAL |
Start Marketing Date | 20080606 |
Marketing Category Name | NDA |
Labeler Name | Cardinal Health |
Substance Name | SEVELAMER HYDROCHLORIDE |
Strength Number | 400 |
Strength Unit | mg/1 |
Pharmaceutical Classes | Phosphate Binder [EPC],Phosphate Chelating Activity [MoA] |